STOCK TITAN

FST Corp (KBSX) enters $10.4M at-the-market ordinary share sales deal

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

FST Corp. has entered into an at-the-market share sales agreement with H.C. Wainwright & Co., allowing it to sell ordinary shares over time with an aggregate offering price of up to $10,400,000. Any shares will be issued under its existing Form F-3 shelf registration.

Sales, if made, can occur on the Nasdaq Global Market or other trading venues and the company is not required to sell any shares. H.C. Wainwright will receive up to 3.0% of the gross sales price. FST also filed an amended prospectus supplement that replaces an earlier supplement it determined was inadvertently filed.

Positive

  • None.

Negative

  • None.
ATM capacity $10,400,000 aggregate offering price Maximum ordinary shares that may be sold under the at-the-market program
Sales agent fee 3.0% of gross sales price Compensation to H.C. Wainwright & Co. for shares sold as sales agent
Shelf registration file number Form F-3 File No. 333-296326 Registration statement covering the at-the-market share sales
Base prospectus date May 28, 2026 Date of the base prospectus accompanying the Form F-3 registration
Sales Agreement date July 6, 2026 Date FST Corp. entered into the At The Market Offering Agreement
At The Market Offering Agreement financial
"On July 6, 2026, FST Corp. entered into an At The Market Offering Agreement"
An at-the-market offering agreement is a contract that lets a company sell newly issued shares directly into the open market through a broker, at whatever price the stock is trading at that moment. For investors this matters because it can increase the number of shares available (which may dilute existing ownership) while providing a flexible, often faster way for the company to raise cash without fixing a price, similar to a vendor selling small batches at current market stalls rather than setting a single fixed price.
shelf registration statement regulatory
"The Shares will be offered and sold pursuant to the Company's shelf registration statement on Form F-3"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
prospectus supplement regulatory
"the Company filed with the Commission a prospectus supplement relating to the offer and sale"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Rule 415 regulatory
"at the market offerings as defined in Rule 415 under the Securities Act of 1933"
Rule 415 is a U.S. Securities and Exchange Commission regulation that lets a company register securities ahead of time and then offer them for sale in pieces over an extended period under a “shelf” registration, so offerings can be launched quickly when market conditions suit the issuer. For investors, it signals that management has a ready way to raise capital fast—useful for seizing opportunities but potentially dilutive to existing shareholders, like a company pre-loading a credit line it can tap as needed.
Form F-3 regulatory
"registration statement on Form F-3 (Registration No. 333-296326)"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
ordinary shares financial
"offer and sell, from time to time through or to the Manager, ordinary shares of the Company"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What at-the-market offering did FST Corp. (KBSX) establish?

FST Corp. established an at-the-market offering allowing it to sell ordinary shares with an aggregate offering price of up to $10,400,000. Shares may be sold over time through H.C. Wainwright & Co. on Nasdaq or other trading markets.

How is H.C. Wainwright compensated in FST Corp.’s ATM program?

H.C. Wainwright will receive up to 3.0% of the gross sales price for any FST Corp. shares it sells as sales agent. This fee is calculated per transaction and only applies to shares actually sold under the agreement.

Is FST Corp. obligated to sell shares under this at-the-market agreement?

FST Corp. is not obligated to sell any shares under the at-the-market agreement. The company may choose whether, when, and how many shares to sell, and there is no assurance that any sales will occur.

Which registration statement covers FST Corp.’s at-the-market sales?

The at-the-market sales are covered by FST Corp.’s shelf registration statement on Form F-3 (File No. 333-296326) and an accompanying base prospectus dated May 28, 2026, together with a prospectus supplement filed on July 6, 2026.

Why did FST Corp. file an amended prospectus supplement?

FST Corp. determined that its original July 2, 2026 prospectus supplement was inadvertently filed. It then submitted an amended prospectus supplement on July 6, 2026, which amends and supersedes the original document in its entirety for the at-the-market offering.

Does FST Corp.’s Form 6-K itself offer or sell any securities?

The Form 6-K does not itself offer or sell securities. It states that it is filed for informational purposes only and does not constitute an offer to sell or solicitation of an offer to buy any securities in any jurisdiction.

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2026

 

Commission File Number: 001-42475

 

FST Corp.

(Registrant’s Name)

 

No. 3, Gongye 1st Rd., Minxiong Township

Chiayi County 621018, Taiwan

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒     Form 40-F ☐

 

 

 

 

 

At The Market Offering Agreement

 

On July 6, 2026, FST Corp. (the “Company”) entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (the “Manager”), pursuant to which the Company may offer and sell, from time to time through or to the Manager, ordinary shares of the Company, par value $0.0001 per share (the “Shares”), having an aggregate offering price of up to $10,400,000. Sales of the Shares, if any, will be made in transactions that are deemed to be “at the market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), including sales made directly on the Nasdaq Global Market, on any other existing trading market for the Company's ordinary shares, or to or through a market maker, or as otherwise agreed with the Manager, including in negotiated transactions with the Manager's prior consent.

 

Under the Sales Agreement, the Manager is entitled to compensation of up to 3.0% of the gross sales price of any Shares sold through it as sales agent. The Company is not obligated to sell any Shares under the Sales Agreement, and no assurance can be given that the Company will sell any Shares under the Sales Agreement, or, if it does, as to the price or amount of Shares that it sells or the timing of any such sales.

 

The Shares will be offered and sold pursuant to the Company's shelf registration statement on Form F-3 (File No. 333-296326), previously filed with and declared effective by the U.S. Securities and Exchange Commission (the “Commission”), and a prospectus supplement relating to the offering filed with the Commission on July 6, 2026.

 

The foregoing description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales Agreement, a copy of which is filed as Exhibit 10.1 to this Report on Form 6-K and is incorporated herein by reference.

 

1

 

 

Corrected Prospectus Supplement

 

On July 2, 2026, the Company filed with the Commission a prospectus supplement (the “Original Prospectus Supplement”), filed pursuant to Rule 424(b)(5) under the Securities Act, relating to the offer and sale from time to time of the Company’s ordinary shares, par value $0.0001 per share, pursuant to the Sales Agreement. The Original Prospectus Supplement relates to the Company’s registration statement on Form F-3 (Registration No. 333-296326) and the accompanying base prospectus, dated May 28, 2026 (the “Base Prospectus”).

 

The Company determined that the Original Prospectus Supplement was inadvertently filed and accordingly, on July 6, 2026, the Company filed with the SEC, pursuant to Rule 424(b)(5) under the Securities Act, an amended prospectus supplement (the “Amended Prospectus Supplement”) that amends and supersedes the Original Prospectus Supplement in its entirety.

 

This report on Form 6-K is filed for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

 

Item 9.01 Financial Statements and Exhibits.

  

(d) Exhibits.

 

Exhibit No.   Description
5.1   Opinion of Ogier
10.1   At The Market Offering Agreement, dated July 6, 2026, between the Company and H.C. Wainwright & Co., LLC

       

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  FST Corp.
     
Date: July 7, 2026 By: /s/ David Chuang
  Name:   David Chuang
  Title: Chief Executive Officer and Chairman of the Board

  

3

 

Filing Exhibits & Attachments

2 documents